Global Pharmaceutical & Biotechnology Outlook 2014: Japan Pharma - KTEN.com - No One Gets You Closer

Global Pharmaceutical & Biotechnology Outlook 2014: Japan Pharma

  • Texoma HeadlinesMore>>

  • Moyers superintendent exempts students from standardized test after tragedy

    Moyers superintendent exempts students from standardized test after tragedy

    MOYERS, OK -- The same standardized test that gave thousands of Oklahoma students problems earlier this week is now giving one Texoma community even more stress. this time, though, it has nothing to do with technical glitches. "I was shocked," Moyers resident Linda Kellett said. People in Moyers are still trying to figure it out. "That's ridiculous. It makes no sense," parent Beth Leinau said. How could two students whose parents died over the weekend ever be expected to focus on a standa...More >>
    MOYERS, OK -- The same standardized test that gave thousands of Oklahoma students problems earlier this week is now giving one Texoma community even more stress. this time, though, it has nothing to do with technical glitches. "I was shocked," Moyers resident Linda Kellett said. People in Moyers are still trying to figure it out. "That's ridiculous. It makes no sense," parent Beth Leinau said. How could two students whose parents died over the weekend ever be expected to focus on a standa...More >>
  • Search For Escaped Inmate Near Atoka County Prison

    Search For Escaped Inmate Near Atoka County Prison

    ATOKA COUNTY, OK -- Right now, authorities are looking for an inmate who escaped from a prison in Atoka County. Kenneth Beasley, 56, was previously convicted of kidnapping and escape in 1999.Sheriff's offices in Atoka and Pushmataha counties tell us this time he's been missing since around 5 p.m. from the Howard McLeod Correctional Facility.His record also includes convictions for robbery.. The prison is located about 10 miles north of Boswell.The prison told us to contact DOC headquarters in...More >>
    ATOKA COUNTY, OK -- Right now, authorities are looking for an inmate who escaped from a prison in Atoka County. Kenneth Beasley, 56, was previously convicted of kidnapping and escape in 1999.Sheriff's offices in Atoka and Pushmataha counties tell us this time he's been missing since around 5 p.m. from the Howard McLeod Correctional Facility.His record also includes convictions for robbery.. The prison is located about 10 miles north of Boswell.The prison told us to contact DOC headquarters in...More >>
  • 83-Year-Old Texoma Woman Arrested For Selling Pot

    83-Year-Old Texoma Woman Arrested For Selling Pot

    PONTOTOC COUNTY, OK -- An 83-year-old Pontotoc County woman was arrested Monday accused of selling dope out of her home. Sheriff john christian says.. "Patsy Marlene Maxwell" was arrested in Stonewall after a month long investigation. Authorities say they found 4 pounds of marmarijuana packagedd ready for distribution inside her home. She faces 2 counts of unlawful distribution of a controlled dangerous substance within 2,000 feet of a school. She was released Monday after posting a $50,000 ...More >>
    PONTOTOC COUNTY, OK -- An 83-year-old Pontotoc County woman was arrested Monday accused of selling dope out of her home. Sheriff john christian says.. "Patsy Marlene Maxwell" was arrested in Stonewall after a month long investigation. Authorities say they found 4 pounds of marmarijuana packagedd ready for distribution inside her home. She faces 2 counts of unlawful distribution of a controlled dangerous substance within 2,000 feet of a school. She was released Monday after posting a $50,000 ...More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Bharat Book Bureau

MUMBAI, India, February 11, 2014 /PRNewswire/ --

Bharat Book Bureau presents Global Pharmaceutical & Biotechnology Outlook 2014: Japan Pharma. 2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations. We find these regulations to be 'decisive' in spurring generic penetration significantly, with the main beneficiary being the Japanese government (or society) and not the generic companies. (http://www.bharatbook.com/biotechnology-market-research-reports/global-pharmaceutical-biotechnology-outlook-2014-japan-pharma.html)

     (Logo: http://photos.prnewswire.com/prnh/20130128/590935 )

The implications of new price-reversions are going to have many facets and will change conventional business models.  We expect many support services industries - CMOs, CROs and other allied services industries to benefit from these structural changes, while API importers will suffer.  We also expect consolidation and M&A activities to spur in Japan.

Innovation Takes the Driver's Seat:  While the new regulations will change the current business philosophy of doing business in patent expired space (>45% to total Japan market), the policy makers also discourage 'me too' innovations at the same time. The regulators however tend to support the 'first time in the world' level innovations by providing 'innovation premiums'.  Japanese innovators will now become more serious and selective in their R&D approach.  Previous year the Japanese innovators have focused on acquiring assets in - autoimmune, orphan diseases and oncology fields (Annexure 5).  We expect this trend to prevail in the coming years.  We find some of the candidates to remain in the limelight in 2014 along with some new additions - Edoxaban (Daiichi Sankyo), Invokana (Mitsubishi Tanabe), Dolutegravir (Shionogi), BBI-608 (Dainippon Sumitomo), Vedolizumab (Takeda), Xtandi (Astellas), Nivolumab (Ono) to hand-pick a few of them. The reports explain detail analysis on these key candidates.

The 138 pages report contains the detailed discussion of Japan biopharmaceutical market - which includes- Our view on the impact of 2014 price cuts on generic companies and innovator companies and detailed discussion on key attributes (consolidation activities, potential of R & D pipeline candidates, generic threat in domestic Japan market etc…) of leading Japanese innovator companies- Astellas, Chugai, Daiichi Sankyo, Dainippon Sumitomo,  Eisai, Kyorin, Kyowa hakko Kirin, Mitsubishi Tanabe, Shionogi,  Takeda and  leading Japanese generic companies- Nippon Chemiphar, Sawai and Towa.

Request for sample pages:  http://www.bharatbook.com/RequestSample.asp?pid=364878

Table of Contents

  • INNOVATORS:
  • New Price-Cuts - A Double Punch To The Innovators!
  • Table 1- New Slabs For Nhi Price Cuts For Long-listed Drugs
  • Table 2 - Expense Vs. Portability Of Japanese Innovators
  • Another Blow For Innovators In Not Institutionalizing The 'Innovation Premium'
  • GENERICS:
  • Pressure To Generic Discount Further Increased
  • Upcoming New Generics
  • Existing Generics
  • Table 3 - New Drug Prices For Existing Ge Drugs
  • Listing Of GE Drugs by Both GE Name And Brand To Promote Discounting
  • IMPLICATIONS:
  • Finding New Avenues Of Cost Saving Are Inevitable For GE Cos
  • Innovators Need To Redone Long-Listed Products Strategies
  • Consolidation Activities To Will Witness A Boost
  • Table 4 - Other REGULATION UNDER APRIL-14 REFORMS*
  • Table 5 -Portably Structure Of Select Generic Companies
  • Annexure 1 JAPAN GEnerics Market Model
  • Annexure 2 Japanese Innovators: Long Listed Exposure
  • Annexure 3 PATENT EXPIRY THROUGH 2016
  • JAPAN INNOVATORS
  • ASTELLAS: Successful Global Launch of Xtandi And Myrbetriq To Overcome Domestic worries!
  • Prograf Generics Launch in Japan
  • Xtandi
  • JP Approval ahead than Zytiga
  • What to watch out for in Detailed PREVAIL data in Late Feb at ASCO GU-14?
  • Prevail top line data of Xtandi - rPFS advantage and ease of use compensate absolute OS disappointment for urologist
  • Recent US prescription trends of Xtandi are encouraging
  • Isavuconazole: Isavuconazole QIDP designation and our expectation
  • Competitive landscape of Antifungals

For more information and complete table of contents:  http://www.bharatbook.com/biotechnology-market-research-reports/global-pharmaceutical-biotechnology-outlook-2014-japan-pharma.html

Related Reports:

Related Category:

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:
Poonam
Bharat Book Bureau
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Blog: http://blog.bharatbook.com
E: poonam@bharatbook.com
W: http://www.bharatbook.com

©2012 PR Newswire. All Rights Reserved.